{"id":13728,"date":"2024-07-09T10:40:52","date_gmt":"2024-07-09T17:40:52","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13728"},"modified":"2024-07-09T10:40:52","modified_gmt":"2024-07-09T17:40:52","slug":"study-tirzepatide-outperforms-semaglutide-in-weight-loss","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/study-tirzepatide-outperforms-semaglutide-in-weight-loss\/","title":{"rendered":"Study: Tirzepatide outperforms semaglutide in weight loss"},"content":{"rendered":"<section class=\"kc-elm kc-css-332574 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-190544 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-612021 kc_text_block\">\n<p class=\"wp-block-paragraph\">A new study by Truveta, published in JAMA Internal Medicine, shows that tirzepatide, or Mounjaro, leads to significantly more weight loss than semaglutide, or Ozempic. Analyzing over 18,000 adults with overweight or obesity, the study found that 82% of tirzepatide users lost at least 5% of their body weight after one year, compared to 67% of semaglutide users, and tirzepatide users also had double the average weight loss at one year.<\/p>\n<p>Full Story: <a href=\"https:\/\/newsletter.smartbrief.com\/uyd\/editProfile.action;jsessionid=83A005EAD64B26858CB7FEAA7D6B8311.web2.smartbrief.com?t1=80666178&amp;t2=https%3A%2F%2Fwww.cnn.com%2F2024%2F07%2F08%2Fhealth%2Fmounjaro-ozempic-weight-loss-study-says%2Findex.html\">CNN<\/a> (7\/8)&nbsp;&nbsp;<\/p>\n<div>&nbsp;<\/div>\n<div>&nbsp;<\/div>\n<div>&nbsp;<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13728","post","type-post","status-publish","format-standard","hentry","category-diabetes-related-news"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13728"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13728\/revisions"}],"predecessor-version":[{"id":13729,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13728\/revisions\/13729"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}